Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC-ι-mediated signaling cascade in glioblastoma

Carcinogenesis

Volumn 33, Issue 1, 2012, Pages 10-19

  Desai, Shraddha R ^a,b   Pillai, Prajit P ^a,b   Patel, Rekha S ^a   McCray, Andrea N ^a   Win Piazza, Hla Y ^a,b   Acevedo Duncan, Mildred E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 7; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C IOTA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; DOWN REGULATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MENINGIOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PURIFICATION; SIGNAL TRANSDUCTION;

EID: 84855371261     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr231     Document Type: Article

References (44)

1. Parlato,C. et al. (2006) Surgery, radiotherapy and temozolomide in treating high-grade gliomas. Front. Biosci., 11, 1280-1283.
2. Stupp,R. et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 352, 987-996.
3. Xiao,H. et al. (1994) The identification of four protein kinase C isoforms in human glioblastoma cell line: PKC alpha, gamma, epsilon and zeta. J. Neurosurg., 81, 734-740.
4. Couldwell,W. et al. (1990) Inhibition of growth of established human glioma cell lines by modulators of the protein kinase C system. J. Neurosurg., 73, 594-600.
5. Inoue,M. et al. (1977) Studies on cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J. Biol. Chem., 252, 7610-7616.
6. Kishimoto,A. et al. (1980) Activation of calcium and phospholipiddependent protein kinase by diacylglycerol, its possible relation to phosphotidylinositol turnover. J. Biol. Chem., 255, 2273-2276.
7. Castagna,M. et al. (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem., 257, 7847-7851.
8. Nelson,D.L. et al. (2001) Biosignaling. Lehninger Principles of Biochemistry. 3rd edn. Worth Publishers. New York, NY, pp. 469.
9. Hiroko,O. (2005) Genetic pathways to glioblastomas. Neuropathology, 25, 1-7.
10. Kesari,S. et al. (2005) Targeted molecular therapy of malignant gliomas. Curr. Neurol. Neurosci. Rep., 5, 186-197.
11. Baldwin,R.M. et al. (2008) Regulation of glioblastoma cell invasion by PKCi and RhoB. Oncogene, 27, 1-9.
12. Baldwin,R.M. et al. (2010) Coordination of glioblastoma cell motility by PKCi. Mol. Cancer, 9, 233-245.
13. Balendran,A. et al. (2000) A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Cf (PKCf) and PKC-related kinase 2 by PDK1. J. Biol. Chem., 275, 20806-20813.
14. Akimoto,K. et al. (1996) EGF or PDGF receptors activate atypical PKCk through phosphatidylinositol 3-kinase. EMBO J., 15, 788-798.
15. Eder,A.M. et al. (2005) Atypical PKC iota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc. Natl Acad. Sci. USA, 102, 12519-12524.
16. Regala,R.P. et al. (2005) Atypical protein kinase Ci is an oncogene in human non-small cell lung cancer. Cancer Res., 65, 8905-8911.
17. Zhang,L. et al. (2006) Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res., 66, 4627-4635.
18. Regala,R.P. et al. (2005) Atypical protein kinase Ci plays a role in human lung cancer cell growth and tumorigenicity. J. Biol. Chem., 180, 31109-31115.
19. Regala,R.P. et al. (2009) Atypical protein kinase C iota is required for bronchioalveolar stem cell expansion and lung tumorigenesis. Cancer Res., 69, 7603-7611.
20. Takagawa,R. et al. (2010) High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence. Ann. Surg. Oncol., 17, 81-88.
21. Murray,N.R. et al. (1997) Atypical protein kinase C iota protects human leukemia cells against drug induced apoptosis. J. Biol. Chem., 272, 27521-27524.
22. Baldwin,R.M. et al. (2006) Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ci-mediated attenuation of p38 MAP kinase signaling. Oncogene, 25, 2909-2919.
23. Lolli,G. et al. (2004) The crystal structure of CDK7 and its protein recognition properties. Structure, 12, 2067-2079.
24. Nigg,E.A. (1996) Cyclin-dependent kinase 7: at the cross-roads DNA repair and cell cycle control? Curr. Opin. Cell Biol., 8, 312-317.
25. Larochelle,S. et al. (2007) Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol. Cell, 25, 839-850.
26. Lolli,G. et al. (2007) Recognition of Cdk2 by CDK7. Proteins, 67, 1048-1059.
27. Aebersold,R. et al. (2008) Identification of CDK2 substrates in human cell lysates. Genome Biol., 9, R149.
28. Patel,R. et al. (2008) Involvement of PKC-i in glioma proliferation. Cell Prolif., 41, 122-135.
29. Acevedo-Duncan,M. et al. (2002) Human glioma PKC-i and PKC-b II phosphorylate cyclin dependent kinase activating kinase during the cell cycle. Cell Prolif., 35, 23-36.
30. Ponten,J. et al. (1968) Long term culture of normal and neoplastic glia. Acta Pathol. Microbiol. Scand., 74, 465-486.
31. Bradford,M.M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the property of protein-dye binding. Anal. Biochem., 72, 248-254.
32. 2+. Biochem. J., 214, 569-574.
33. Pillai,P. et al. (2011) A novel PKC-i inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma. Int. J. Biochem. Cell Biol., 43, 784-794.
34. Desai,S. et al. (2011) PKC-i promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphotidylinositol 3-kinase pathway. Biochim. Biophys. Acta, 1813, 1190-1197.
35. Win,H.Y. et al. (2008) Atypical protein kinase C phosphorylates IKKαβ in transformed non-malignant and malignant prostate cell survival. Cancer Lett., 270, 302-311.
36. Akiyama,T. et al. (1992) Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl Acad. Sci. USA, 89, 7900-7904.
37. Dyson,N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev., 12, 2245-2262.
38. Montagnoli,A. et al. (1999) Ubiquitination of p27 is regulated by Cdkdependent phosphorylation and trimeric complex formation. Genes Dev., 13, 1181-1189.
39. Scotti,M.L. et al. (2010) Protein kinase Ci is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res., 70, 2064-2074.
40. Collins,B.J. et al. (2005) In vivo role of the phosphate groove of PDK1 defined by knockin mutation. J. Cell Sci., 118, 5023-5034.
41. Cacace,A.M. et al. (1993) The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene, 8, 2095-2104.
42. Basu,A. et al. (2007) Protein kinase Cepsilon makes the life and death decision. Cell Signal., 19, 1633-1642.
43. Sharif,T.R. et al. (1999) Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples. Int. J. Oncol., 15, 237-243.
44. Sharif,T.R. et al. (2001) Regulated expression of dominant negative protein kinase C epsilon mutant inhibits the proliferation of U373MG human astrocytoma cells. Int. J. Mol. Med., 7, 373-380.